Laxai Pharma LtdOver The Counter Market:LAXAF
- LAST PRICE0.0001
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.0000 / 0.0001
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Laxai Pharma Ltd | 6.3K | 0.0x | --- |
Arno Therapeutics Inc | 50.0 | 0.0x | --- |
HempAmericana Inc | 2.9K | 0.0x | --- |
Gene Biotherapeutics Inc | 60.0 | 0.0x | --- |
Tengion Inc | 40.0 | 0.0x | --- |
Anthera Pharmaceuticals Inc | 2.6K | 0.0x | --- |
Company Information
Laxai Pharma, Ltd. (Laxai), formerly NexGen Biofuels Ltd., is a development-stage company. From March 2010, Laxai, through its fully owned subsidiary OSR Holding Corp., is engaged in the business of providing integrated services across the drug development spectrum out of Laxai subsidiary’s leased facilities in South Plainfield, New Jersey, United States of America. Laxai was engaged through February 2010, in the development and/or acquisition of ethanol and bio-diesel plants, and blending terminal facilities, in the United States. In February 2010, the Company ceased its ethanol and bio-diesel activities. On March 3, 2010, OSR Holding Corp. acquired all the assets of OSR Solutions, Inc. The Company focuses on offering medicinal chemistry, research & development processes, clinical research, collaborative research and blended onshore/off-shore model.
Contact Information
- Headquarters
- 8905 Regents Park Dr, Suite 210TAMPA, FL, United States 33647
- Phone
- 813-428-3500
- Fax
- ---
Executives
- Chairman of the Board, Managing Director
- Vamsi Maddipatla
- Chief Executive Officer
- Ram Upadhayaya
- Chief Financial Officer
- Nikhil Baheti
- EVP, Preclinical Biology & DMPK
- Ramesh Mullangi
- Chief Scientific Officer and Head of R& D
- Raghava Kethiri
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $6.3K |
|---|---|
Revenue (TTM) | $3.1M |
Shares Outstanding | 63.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 3.30 |
EPS | $-0.03 |
Book Value | $-0.03 |
P/E Ratio | 0.0x |
Price/Sales (TTM) | 0.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -49.59% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
